235 related articles for article (PubMed ID: 38146310)
21. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
22. Mpox Virus in Pregnancy, the Placenta, and Newborn.
Schwartz DA; Ha S; Dashraath P; Baud D; Pittman PR; Adams Waldorf KM
Arch Pathol Lab Med; 2023 Jul; 147(7):746-757. PubMed ID: 36857117
[TBL] [Abstract][Full Text] [Related]
23. Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox.
Adamo S; Gao Y; Sekine T; Mily A; Wu J; Storgärd E; Westergren V; Filén F; Treutiger CJ; Sandberg JK; Sällberg M; Bergman P; Llewellyn-Lacey S; Ljunggren HG; Price DA; Ekström AM; Sette A; Grifoni A; Buggert M
Cell Host Microbe; 2023 Jun; 31(6):928-936.e4. PubMed ID: 37236191
[TBL] [Abstract][Full Text] [Related]
24. Monkeypox: A New Threat?
Kmiec D; Kirchhoff F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887214
[TBL] [Abstract][Full Text] [Related]
25. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
[TBL] [Abstract][Full Text] [Related]
26. Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances.
Wang Y
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632084
[TBL] [Abstract][Full Text] [Related]
27. A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge.
Parker S; D'Angelo J; Buller RM; Smee DF; Lantto J; Nielsen H; Jensen A; Prichard M; George SL
Antiviral Res; 2021 Nov; 195():105179. PubMed ID: 34530009
[TBL] [Abstract][Full Text] [Related]
28. Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge.
Noyce RS; Westfall LW; Fogarty S; Gilbert K; Mpanju O; Stillwell H; Esparza J; Daugherty B; Koide F; Evans DH; Lederman S
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851570
[TBL] [Abstract][Full Text] [Related]
29. Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies.
Roper RL; Garzino-Demo A; Del Rio C; Bréchot C; Gallo R; Hall W; Esparza J; Reitz M; Schinazi RF; Parrington M; Tartaglia J; Koopmans M; Osorio J; Nitsche A; Huan TB; LeDuc J; Gessain A; Weaver S; Mahalingam S; Abimiku A; Vahlne A; Segales J; Wang L; Isaacs SN; Osterhaus A; Scheuermann RH; McFadden G
Vaccine; 2023 May; 41(20):3171-3177. PubMed ID: 37088603
[TBL] [Abstract][Full Text] [Related]
30. Monkeypox: a global health emergency.
Stilpeanu RI; Stercu AM; Stancu AL; Tanca A; Bucur O
Front Microbiol; 2023; 14():1094794. PubMed ID: 37180247
[TBL] [Abstract][Full Text] [Related]
31. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.
Karagoz A; Tombuloglu H; Alsaeed M; Tombuloglu G; AlRubaish AA; Mahmoud A; Smajlović S; Ćordić S; Rabaan AA; Alsuhaimi E
J Infect Public Health; 2023 Apr; 16(4):531-541. PubMed ID: 36801633
[TBL] [Abstract][Full Text] [Related]
32. Monkeypox disease transmission in an experimental setting: prairie dog animal model.
Hutson CL; Carroll DS; Gallardo-Romero N; Weiss S; Clemmons C; Hughes CM; Salzer JS; Olson VA; Abel J; Karem KL; Damon IK
PLoS One; 2011; 6(12):e28295. PubMed ID: 22164263
[TBL] [Abstract][Full Text] [Related]
33. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development.
Andrei G; Snoeck R
Trends Pharmacol Sci; 2023 Oct; 44(10):719-739. PubMed ID: 37673695
[TBL] [Abstract][Full Text] [Related]
34. Monkeypox Virus and Ophthalmology-A Primer on the 2022 Monkeypox Outbreak and Monkeypox-Related Ophthalmic Disease.
Kaufman AR; Chodosh J; Pineda R
JAMA Ophthalmol; 2023 Jan; 141(1):78-83. PubMed ID: 36326768
[TBL] [Abstract][Full Text] [Related]
35. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history.
Xia A; Wang X; He J; Wu W; Jiang W; Xue S; Zhang Q; Gao Y; Han Y; Li Y; Peng X; Xie M; Mayer CT; Liu J; Hua C; Sha Y; Xu W; Huang J; Ying T; Jiang S; Xie Y; Cai Q; Lu L; Silva IT; Yuan Z; Zhang Y; Wang Q
BMC Biol; 2023 Oct; 21(1):205. PubMed ID: 37784185
[TBL] [Abstract][Full Text] [Related]
36. The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon.
Fernández de Marco Mdel M; Alejo A; Hudson P; Damon IK; Alcami A
FASEB J; 2010 May; 24(5):1479-88. PubMed ID: 20019241
[TBL] [Abstract][Full Text] [Related]
37. Antivirals against monkeypox infections.
Chiem K; Nogales A; Lorenzo M; Vasquez DM; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Mart Nez-Sobrido L
bioRxiv; 2023 Apr; ():. PubMed ID: 37131608
[TBL] [Abstract][Full Text] [Related]
38. The land-scape of immune response to monkeypox virus.
Li H; Huang QZ; Zhang H; Liu ZX; Chen XH; Ye LL; Luo Y
EBioMedicine; 2023 Jan; 87():104424. PubMed ID: 36584594
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
De Clercq E; Jiang Y; Li G
Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
[TBL] [Abstract][Full Text] [Related]
40. Correlates of protective immunity in poxvirus infection: where does antibody stand?
Panchanathan V; Chaudhri G; Karupiah G
Immunol Cell Biol; 2008 Jan; 86(1):80-6. PubMed ID: 17923850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
